Multicentre Observational Study on Community Acquired Intraabdominal Infections Management (PERICOM)

November 24, 2025 updated by: Centre Hospitalier Universitaire de Nīmes

Multicentre Observational Study on Community Acquired Intraabdominal Infections Management: the PERICOM Study

Intraabdominal infection require rapid care management including antibiotic therapy and source control. Morbidity and mortality associated with Intraabdominal infections remain high. French recommendations have been edited in 2000 further updated in 2014. Delay in diagnosis and surgery can lead to worsened outcomes. However, little data are available on early community-acquired intraabdominal infections management to identify risk factors of inadequate management.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Angers, France, 49033
        • CHU Angers
      • Clamart, France
        • HIA Percy
      • Clermont-Ferrand, France, 63000
        • Chu Clermont-Ferrand
      • Créteil, France, 94010
        • Hôpital Henri Mondor
      • Grenoble, France, 38700
        • CHU Grenoble La Tronche
      • Lille, France, 59037
        • CHRU LILLE
      • Lyon, France
        • Lyon-Sud Pierre Bénite
      • Marseille, France
        • Ap Hm La Timone
      • Nîmes, France, 30029
        • CHU Nîmes
      • Paris, France, 75018
        • Chu Bichat Claude Bernard
      • Strasbourg, France
        • CHU Strasbourg
    • Amiens
      • Amiens, Amiens, France, 80054
        • CHU d'Amiens
    • Marseille
      • Marseille, Marseille, France, 13385
        • Ap Hm La Timone
    • Paris
      • Paris, Paris, France, 94270
        • Le Kremlin-Bicêtre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

patients admitted to emergency department for a diagnosis of proven or suspected intraabdominal infection requiring surgery

Description

Inclusion Criteria:

  • ≥ 18 years
  • patients admitted to emergency department for a diagnosis of proven or suspected intraabdominal infection requiring surgery

Exclusion Criteria:

  • primary intraabdominal infection
  • health-care associated intraabdominal infection
  • abdominal trauma
  • patient under guardianship
  • opt out consent
  • patient already enrolled in the present study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
length of stay
Time Frame: 6 month
6 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2018

Primary Completion (Actual)

February 10, 2019

Study Completion (Actual)

February 10, 2019

Study Registration Dates

First Submitted

May 22, 2018

First Submitted That Met QC Criteria

May 22, 2018

First Posted (Actual)

June 1, 2018

Study Record Updates

Last Update Posted (Actual)

December 1, 2025

Last Update Submitted That Met QC Criteria

November 24, 2025

Last Verified

January 1, 2019

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intraabdominal Infections

Subscribe